Exenatide strongly decreased pre-S1 BGL specifically in the b S1 v S2 meal schedule condition (d = 2.38 0.25 mmol/L, t 6.8 = 9.7, p = 3 10 5 , uncorrected contrast), and only to a smaller extent in the other conditions (d 0.73, t 3.5, p 0.006
doi: 10.1371/journal.pone.0046083 75 ShiQLiuYYangWLiYWangCGaoK
According to the Summary of Product Characteristics (SmPC), serious hypersensitivity reactions including anaphylaxis and angioedema have been reported with semaglutide in post-marketing surveillance
If your knees feel better tomorrow, that's probably not collagen, it's usually inflammation changes, training adjustments, or reduced load
Get mobile IV and peptide therapy near you for dehydration, hangovers, fatigue, low immunity and more
Mood swings are not listed as a recognised side effect in the MHRA-approved Summary of Product Characteristics for Rybelsus